Financials · mywealthgrid

Standalone figures · ₹ crore

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	344	225	213	222	236	275	330	484	498	482	568	360
COGS	99	56	67	57	46	47	131	146	138	157	211	111
Gross profit	245	169	146	165	190	228	200	338	359	325	356	249
	75	71	78	82	89	113	132	233	229	222	240	223
	170	97	68	83	101	115	67	104	131	103	117	26
OPM %	49.4%	43.3%	32%	37.4%	42.8%	41.9%	20.4%	21.6%	26.3%	21.3%	20.5%	7.4%
Depreciation	11	10	11	12	12	13	15	31	31	33	38	34
Interest	1	1	1	2	1	3	2	7	5	5	5	2
	10	14	14	18	13	15	7	5	26	1	-17	12
Profit before tax	168	101	70	87	101	115	56	71	121	65	56	2
Tax	43	26	17	22	24	28	12	18	26	18	22	1
Tax %	25.9%	25.7%	24.7%	25.5%	24.2%	24.7%	21.3%	26%	21.9%	27.7%	38.8%	36.2%
	124	75	52	65	76	86	44	53	94	47	35	1
PAT margin %	36.1%	33.3%	24.6%	29.3%	32.3%	31.4%	13.4%	10.9%	18.9%	9.8%	6.1%	0.4%
EPS (₹)	4.9	2.9	2.1	2.6	3	3.4	1.7	1.4	2.5	1.2	0.9	0
Results filing	—	—	—	—	—	—	—	Results filing for Jun 2025	Results filing for Sep 2025	Results filing for Dec 2025	Results filing for Mar 2026	—

vs same quarter last year	Jun 2023	Sep 2023	Dec 2023	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+1.5%	-19.3%	-38.9%	-39.1%	-31.4%	+22.6%	+55.1%	+117.7%

Cohance Lifesciences Limited